bars). (G)
In vitro adhesion assay: EMC4 cells pretreated with either ibrutinib (10 nM) or idelalisib (100 nM) or a combination were allowed to adhere to fibronectin-coated surfaces (n = 3, in triplicate). Graphs are presented as normalized mean ± SD (100%= EMC4 cells treated with vehicle). **P < 0.01 ***P < 0.0001 (paired one-sample T-test) . 
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